Post-earnings recap
Reported
Thu, Nov 9, 2017
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
This earnings report shows that Charles River Laboratories was able to exceed EPS expectations, but the stock reacted negatively, dropping 12.69%. The decline may be attributed to broader market concerns and management's cautious tone regarding future challenges. Investors are likely looking for clearer guidance and reassurance in the upcoming quarters.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.30 | N/A | +2.39% |
| Revenue | N/A | N/A | N/A |
Management expressed concerns about current market conditions and indicated a cautious approach to future planning. They did not provide specific guidance for the upcoming quarters.
Management highlighted ongoing challenges in the market.
They emphasized the need for strategic adjustments moving forward.